Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression (Q40254650)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 July 2006
edit
Language Label Description Also known as
English
Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression
scientific article published on 17 July 2006

    Statements

    Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression (English)
    Javier A Menendez
    Inderjit Mehmi
    Ruth Lupu
    17 July 2006
    3735-3746

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit